Successful capital raising for Gedea Biotech

December 20, 2017
Gedea Biotech AB

Gedea Biotech has raised 11 MSEK for clinical trials throughout 2018, to verify the treatment of vaginal infections. The share issue has attracted a large interest from investors and was expanded from estimated 7 MSEK to 11 MSEK.

Read more here